Even if Amarin prevails in its patent infringement lawsuit, its key patents on Vascepa are likely to be ruled invalid in ongoing litigation, opening the way for generic formulations.

中文翻译：

---

Vascepa 专利受到法律审查

即使 Amarin 在其专利侵权诉讼中胜诉，其有关 Vascepa 的关键专利也可能在正在进行的诉讼中被裁定为无效，从而为仿制药开辟道路。